Free Trial

McKesson (MCK) Stock Forecast & Price Target

McKesson logo
$741.89 +3.83 (+0.52%)
As of 03:37 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

McKesson - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Sell
0
Hold
3
Buy
13

Based on 16 Wall Street analysts who have issued ratings for McKesson in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 16 analysts, 3 have given a hold rating, 12 have given a buy rating, and 1 has given a strong buy rating for MCK.

Consensus Price Target

$829.08
11.75% Upside
According to the 16 analysts' twelve-month price targets for McKesson, the average price target is $829.08. The highest price target for MCK is $864.00, while the lowest price target for MCK is $688.00. The average price target represents a forecasted upside of 11.75% from the current price of $741.89.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for MCK and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for McKesson and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MCK Analyst Ratings Over Time

TypeCurrent Forecast
10/6/24 to 10/6/25
1 Month Ago
9/6/24 to 9/6/25
3 Months Ago
7/8/24 to 7/8/25
1 Year Ago
10/7/23 to 10/6/24
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
12 Buy rating(s)
9 Buy rating(s)
10 Buy rating(s)
12 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
3 Hold rating(s)
4 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$829.08$725.10$696.42$613.36
Forecasted Upside11.75% Upside5.54% Upside-3.79% Downside26.36% Upside
Consensus RatingModerate BuyModerate BuyModerate BuyModerate Buy

MCK Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

MCK Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

McKesson Stock vs. The Competition

TypeMcKessonMedical CompaniesS&P 500
Consensus Rating Score
2.88
2.33
2.51
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside12.34% Upside1,415.12% Upside10.49% Upside
News Sentiment Rating
Positive News

See Recent MCK News
Positive News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
9/27/2025Weiss Ratings
0 of 5 stars
 Reiterated RatingBuy (B)
9/26/2025JPMorgan Chase & Co.
2 of 5 stars
Lisa Gill
Lisa Gill
Not Rated
Boost TargetOverweight$821.00 ➝ $853.00+15.64%
9/24/2025Evercore ISI
3 of 5 stars
Boost TargetOutperform$800.00 ➝ $825.00+8.10%
9/24/2025Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Reiterated RatingBuy
9/24/2025Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetBuy$820.00 ➝ $860.00+16.30%
9/24/2025TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetBuy$830.00 ➝ $864.00+13.63%
9/24/2025Mizuho
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetNeutral$750.00 ➝ $770.00+1.16%
9/24/2025Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetOverweight$810.00 ➝ $857.00+15.89%
9/24/2025UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetBuy$820.00 ➝ $860.00+16.30%
9/24/2025Leerink Partners
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetOutperform$785.00 ➝ $850.00+14.95%
9/24/2025Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetEqual Weight$772.00 ➝ $816.00+10.35%
9/24/2025Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetBuy$775.00 ➝ $856.00+15.76%
9/24/2025Bank of America
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetBuy$800.00 ➝ $850.00+14.95%
4/4/2025Cfra Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeModerate BuyHold
11/7/2024Baird R W
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHoldStrong-Buy
11/7/2024Robert W. Baird
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 UpgradeNeutralOutperform$531.00 ➝ $688.00+25.25%
8/8/2024Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Boost TargetOverweight$596.00 ➝ $616.00+12.78%
6/24/2024Argus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Boost TargetBuy$570.00 ➝ $670.00+11.10%
2/26/2024Leerink Partnrs
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 03:37 PM ET.


Should I Buy McKesson Stock? MCK Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Sunday, October 5, 2025. Please send any questions or comments about these McKesson pros and cons to contact@marketbeat.com.

McKesson
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in McKesson Co.:

  • Recent upgrades from major financial institutions have increased the price targets for McKesson Co., indicating strong confidence in the company's future performance.
  • The current stock price is around $738, which reflects a significant increase from its 1-year low, suggesting a positive trend in the company's valuation.
  • McKesson Co. has a solid dividend yield of 0.4%, which can provide a steady income stream for investors, especially in a volatile market.
  • With a market capitalization of approximately $91.80 billion, McKesson Co. is a major player in the healthcare sector, which can offer stability and growth potential.
  • The company has received a "Moderate Buy" average rating from analysts, with a majority recommending the stock, which can be a positive indicator for potential investors.

McKesson
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in McKesson Co. for these reasons:

  • Insider selling has been notable, with significant shares sold by executives, which may raise concerns about their confidence in the company's future performance.
  • The stock has experienced fluctuations, with a recent decline of about 2.7%, indicating potential volatility that could deter risk-averse investors.
  • Despite a strong market position, McKesson Co. operates in a highly competitive industry, which can impact its market share and profitability.
  • The company's payout ratio is relatively low at 13.08%, which may suggest limited growth in dividends in the near term, potentially disappointing income-focused investors.
  • Analysts have mixed opinions, with some holding a "Hold" rating, indicating that not all experts are convinced of the stock's immediate upside potential.

MCK Forecast - Frequently Asked Questions

According to the research reports of 16 Wall Street equities research analysts, the average twelve-month stock price forecast for McKesson is $829.08, with a high forecast of $864.00 and a low forecast of $688.00.

16 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for McKesson in the last twelve months. There are currently 3 hold ratings, 12 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" MCK shares.

According to analysts, McKesson's stock has a predicted upside of 11.75% based on their 12-month stock forecasts.

Analysts like McKesson more than other "medical" companies. The consensus rating for McKesson is Moderate Buy while the average consensus rating for "medical" companies is Hold. Learn more on how MCK compares to other companies.


This page (NYSE:MCK) was last updated on 10/6/2025 by MarketBeat.com Staff
From Our Partners